Leipzig, 04/2010 -AJ Roboscreen obtained CE mark and lot approval documents for the RoboGene® HBV DNA Quantification Kit
AJ Roboscreen informs that we recently obtained the EC certificates stating that the Quality System and Design Examination concerning the RoboGene® HBV DNA Quantification Kit showing are conform to the European IvD regulations. Therefore it is proven that both the quality system and the design examination of the kit which ... [mehr]
Leipzig, 01/2010 - AJ Roboscreen became newly certified according to the DIN EN ISO 9001:2008 and DIN EN ISO 13485:2007 norms by mdc medical device certification GmbH, Stuttgart
We are proud to inform that we recently established a new IvD production unit at AJ Roboscreen and that we obtained the DIN EN ISO 9001:2008 and DIN EN ISO 13485:2007 certificates issued by the German notified body mdc Stuttgart. This brings us now in the position to manufacture CE ... [mehr]
Leipzig, 01/2009 - BetaPrion® Scrapie EIA test kit for research
The BetaPrion® Scrapie EIA test kit is a post mortem assay that detects both typical and atypical SCRAPIE in samples from sheep and goat. The kit uses Proteinase K and is based on sandwich ELISA with two monoclonal antibodies. Recently, this kit is in process of validation by the EFSA ... [mehr]
Leipzig, 11/2008 - antibodies for Alzheimer and Parkinson research
New antibodies developed by AJ Roboscreen GmbH are now available for Alzheimer and Parkinson research.
... [mehr]
11/02/2007- Analytik Jena-subsidiary have got the rights of sale from rPeptide
Leipzig, November 02, 2007 - With effect from 11/02/2007 the AJ Roboscreen GmbH, a subsidiary company of Analytik Jena Co., have got the rights of sale for the whole product portfolio from rPeptide, Bogart USA, to distribute their products in Germany/Europe. The US biotechnology company rPeptide is a market leader ... [mehr]
11/14/2006 Analytik Jena-subsidiary obtains approval of improved BSE test kit
Leipzig, 14.11.2006 The Leipzig-based biotechnology company, AJ Roboscreen, has obtained approval from the EU TSE Reference Laboratory of an improved BetaPrion BSE EIA Test Kit. The analysis time has been markedly shortened from 3 hours 10 minutes to only 1 hour 40 minutes, which was possible based on the ... [mehr]
03/31/2005 Analytik Jena AG becomes majority shareholder in the biotech company Roboscreen
Jena/Leipzig, March 31, 2005 - Analytik Jena (DE0005213508), with a stake of 51.0%, has become the majority shareholder in the Leipzig-based biotech company Roboscreen Gesellschaft fr molekulare Biotechnologie mbH.
Roboscreen GmbH was founded in 2000 by four molecular biologists. The company develops and manufactures technologies and products for automated ... [mehr]
02/16/2005 Approval of Roboscreen BetaPrion BSE EIA Test Kit
European Commission approves Roboscreen BetaPrion BSE EIA Test Kit
Link:
PDF-Download ... [mehr]
02/13/2005 Arab Health Dubai
Roboscreen exhibits on the booth of Al Hayat Pharmaceuticals at the Arab Health in Dubai (U.A.E.) ... [mehr]
01/18/2005 Workshop Jordanien
Roboscreen/Envirolife Workshop & Product Presentation PCR in Amman (Jordan): Theoretical & practical session ... [mehr]
01/22/2005 European College of Equine Internal Medicine in Leipzig
Roboscreen exhibition at the ECEIM - European College of Equine Internal Medicine in Leipzig ... [mehr]
11/18/2004 Roboscreen BetaPrion rapid BSE test recommended for approval by EFSA
As the sole German player the young Saxonian biotech company Roboscreen GmbH succeded to place it`s BSE rapid test among the 7 new tests recently recommended for approval by the European Commission. This was announced on November 18 by the scientific report of the European Food Safety Authority (EFSA) on ... [mehr]
29.07.2004 Roboscreen lizensiert Antikörper an die Prionics AG
Die Roboscreen Gesellschaft fr molekulare Biotechnologie mbH mit Sitz in Leipzig (Deutschland) gibt den Abschluà einer Lizenzvereinbarung mit dem fhrenden Prionendiagnostik-Unternehmen Prionics AG (Schweiz) bekannt. Die Prionics AG erwirbt eine Lizenz fr die Nutzung eines von Roboscreen entwickelten monoklonalen Antikrpers mit Spezifitt fr ein Prionenprotein und evaluiert den Antikrper fr ... [mehr]
02.02.2004 Leipziger Biotech-Unternehmen entwickelt BSE-Test in Rekordzeit
Als erstem deutschen Biotechnologieunternehmen ist es der in Leipzig ansssigen Roboscreen Gesellschaft fr molekulare Biotechnologie mbH (11 Mitarbeiter) gelungen, in nur 12 Monaten einen kompletten hochsensitiven post mortem BSE-Test zu entwickeln. Alle essentiellen Test-Bausteine (rekombinantes Prionprotein, monoklonale Antikrper, etc.) stellen Eigenentwicklungen dar. Die Rechte an der Vermarktung befinden sich komplett ... [mehr]
|
